世界の経口用固形剤形医薬品市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Oral Solid Dosage Pharmaceutical Formulation Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z4306 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品、ヘルスケア

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、経口用固形剤形医薬品のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（即時放出性、持続放出性、その他）、用途別市場規模（病院薬局、小売薬局、ドラッグストア、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・経口用固形剤形医薬品の市場動向 ・企業の競争状況、市場シェア ・経口用固形剤形医薬品の種類別市場規模（即時放出性、持続放出性、その他） ・経口用固形剤形医薬品の用途別市場規模（病院薬局、小売薬局、ドラッグストア、その他） ・経口用固形剤形医薬品の北米市場規模2016-2027（アメリカ、カナダ） ・経口用固形剤形医薬品のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・経口用固形剤形医薬品のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・経口用固形剤形医薬品の中南米市場規模2016-2027（メキシコ、ブラジル） ・経口用固形剤形医薬品の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（AstraZeneca、Bristol-Myers Squibb、Eli Lilly、Gilead、Merck、Novartis、Pfizer、AbbVie、Boehringer Ingelheim） ・結論

Oral solid dosage forms are the most commonly used pharmaceuticals to treat various disease conditions. Oral solid dosage forms are cost-effective and easy to manufacture in comparison with other dosage forms. They offer significant benefits to manufacturers such as trouble free packaging and transportation and increased chemical and physical stability. Oral solids offer many advantages to patients as well.
North America dominated the global oral solid dosage pharmaceutical formulation market in revenue terms in 2017, and the trend is projected to continue throughout the forecast period.

Market Analysis and Insights: Global Oral Solid Dosage Pharmaceutical Formulation Market
The global Oral Solid Dosage Pharmaceutical Formulation market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Oral Solid Dosage Pharmaceutical Formulation market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Oral Solid Dosage Pharmaceutical Formulation market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Oral Solid Dosage Pharmaceutical Formulation market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Oral Solid Dosage Pharmaceutical Formulation market.

Global Oral Solid Dosage Pharmaceutical Formulation Scope and Market Size
Oral Solid Dosage Pharmaceutical Formulation market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Oral Solid Dosage Pharmaceutical Formulation market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Immediate Release
Extended Release
Others

Segment by Application
Hospital Pharmacy
Retail Pharmacy
Drug Stores
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
Gilead
Merck
Novartis
Pfizer
AbbVie
Boehringer Ingelheim

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oral Solid Dosage Pharmaceutical Formulation Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Immediate Release
1.2.3 Extended Release
1.2.4 Others
1.3 Market by Application
1.3.1 Global Oral Solid Dosage Pharmaceutical Formulation Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Drug Stores
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Oral Solid Dosage Pharmaceutical Formulation Market Perspective (2016-2027)
2.2 Oral Solid Dosage Pharmaceutical Formulation Growth Trends by Regions
2.2.1 Oral Solid Dosage Pharmaceutical Formulation Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Oral Solid Dosage Pharmaceutical Formulation Historic Market Share by Regions (2016-2021)
2.2.3 Oral Solid Dosage Pharmaceutical Formulation Forecasted Market Size by Regions (2022-2027)
2.3 Oral Solid Dosage Pharmaceutical Formulation Industry Dynamic
2.3.1 Oral Solid Dosage Pharmaceutical Formulation Market Trends
2.3.2 Oral Solid Dosage Pharmaceutical Formulation Market Drivers
2.3.3 Oral Solid Dosage Pharmaceutical Formulation Market Challenges
2.3.4 Oral Solid Dosage Pharmaceutical Formulation Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Oral Solid Dosage Pharmaceutical Formulation Players by Revenue
3.1.1 Global Top Oral Solid Dosage Pharmaceutical Formulation Players by Revenue (2016-2021)
3.1.2 Global Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Players (2016-2021)
3.2 Global Oral Solid Dosage Pharmaceutical Formulation Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Oral Solid Dosage Pharmaceutical Formulation Revenue
3.4 Global Oral Solid Dosage Pharmaceutical Formulation Market Concentration Ratio
3.4.1 Global Oral Solid Dosage Pharmaceutical Formulation Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oral Solid Dosage Pharmaceutical Formulation Revenue in 2020
3.5 Oral Solid Dosage Pharmaceutical Formulation Key Players Head office and Area Served
3.6 Key Players Oral Solid Dosage Pharmaceutical Formulation Product Solution and Service
3.7 Date of Enter into Oral Solid Dosage Pharmaceutical Formulation Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Oral Solid Dosage Pharmaceutical Formulation Breakdown Data by Type
4.1 Global Oral Solid Dosage Pharmaceutical Formulation Historic Market Size by Type (2016-2021)
4.2 Global Oral Solid Dosage Pharmaceutical Formulation Forecasted Market Size by Type (2022-2027)

5 Oral Solid Dosage Pharmaceutical Formulation Breakdown Data by Application
5.1 Global Oral Solid Dosage Pharmaceutical Formulation Historic Market Size by Application (2016-2021)
5.2 Global Oral Solid Dosage Pharmaceutical Formulation Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Oral Solid Dosage Pharmaceutical Formulation Market Size (2016-2027)
6.2 North America Oral Solid Dosage Pharmaceutical Formulation Market Size by Type
6.2.1 North America Oral Solid Dosage Pharmaceutical Formulation Market Size by Type (2016-2021)
6.2.2 North America Oral Solid Dosage Pharmaceutical Formulation Market Size by Type (2022-2027)
6.2.3 North America Oral Solid Dosage Pharmaceutical Formulation Market Size by Type (2016-2027)
6.3 North America Oral Solid Dosage Pharmaceutical Formulation Market Size by Application
6.3.1 North America Oral Solid Dosage Pharmaceutical Formulation Market Size by Application (2016-2021)
6.3.2 North America Oral Solid Dosage Pharmaceutical Formulation Market Size by Application (2022-2027)
6.3.3 North America Oral Solid Dosage Pharmaceutical Formulation Market Size by Application (2016-2027)
6.4 North America Oral Solid Dosage Pharmaceutical Formulation Market Size by Country
6.4.1 North America Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2016-2021)
6.4.2 North America Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Oral Solid Dosage Pharmaceutical Formulation Market Size (2016-2027)
7.2 Europe Oral Solid Dosage Pharmaceutical Formulation Market Size by Type
7.2.1 Europe Oral Solid Dosage Pharmaceutical Formulation Market Size by Type (2016-2021)
7.2.2 Europe Oral Solid Dosage Pharmaceutical Formulation Market Size by Type (2022-2027)
7.2.3 Europe Oral Solid Dosage Pharmaceutical Formulation Market Size by Type (2016-2027)
7.3 Europe Oral Solid Dosage Pharmaceutical Formulation Market Size by Application
7.3.1 Europe Oral Solid Dosage Pharmaceutical Formulation Market Size by Application (2016-2021)
7.3.2 Europe Oral Solid Dosage Pharmaceutical Formulation Market Size by Application (2022-2027)
7.3.3 Europe Oral Solid Dosage Pharmaceutical Formulation Market Size by Application (2016-2027)
7.4 Europe Oral Solid Dosage Pharmaceutical Formulation Market Size by Country
7.4.1 Europe Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2016-2021)
7.4.2 Europe Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Size (2016-2027)
8.2 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Size by Type
8.2.1 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Size by Type (2016-2027)
8.3 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Size by Application
8.3.1 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Size by Application (2016-2027)
8.4 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Size by Region
8.4.1 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Oral Solid Dosage Pharmaceutical Formulation Market Size (2016-2027)
9.2 Latin America Oral Solid Dosage Pharmaceutical Formulation Market Size by Type
9.2.1 Latin America Oral Solid Dosage Pharmaceutical Formulation Market Size by Type (2016-2021)
9.2.2 Latin America Oral Solid Dosage Pharmaceutical Formulation Market Size by Type (2022-2027)
9.2.3 Latin America Oral Solid Dosage Pharmaceutical Formulation Market Size by Type (2016-2027)
9.3 Latin America Oral Solid Dosage Pharmaceutical Formulation Market Size by Application
9.3.1 Latin America Oral Solid Dosage Pharmaceutical Formulation Market Size by Application (2016-2021)
9.3.2 Latin America Oral Solid Dosage Pharmaceutical Formulation Market Size by Application (2022-2027)
9.3.3 Latin America Oral Solid Dosage Pharmaceutical Formulation Market Size by Application (2016-2027)
9.4 Latin America Oral Solid Dosage Pharmaceutical Formulation Market Size by Country
9.4.1 Latin America Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2016-2021)
9.4.2 Latin America Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Size (2016-2027)
10.2 Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Size by Type
10.2.1 Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Size by Type (2016-2027)
10.3 Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Size by Application
10.3.1 Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Size by Application (2016-2027)
10.4 Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Size by Country
10.4.1 Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Details
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Oral Solid Dosage Pharmaceutical Formulation Introduction
11.1.4 AstraZeneca Revenue in Oral Solid Dosage Pharmaceutical Formulation Business (2016-2021)
11.1.5 AstraZeneca Recent Development
11.2 Bristol-Myers Squibb
11.2.1 Bristol-Myers Squibb Company Details
11.2.2 Bristol-Myers Squibb Business Overview
11.2.3 Bristol-Myers Squibb Oral Solid Dosage Pharmaceutical Formulation Introduction
11.2.4 Bristol-Myers Squibb Revenue in Oral Solid Dosage Pharmaceutical Formulation Business (2016-2021)
11.2.5 Bristol-Myers Squibb Recent Development
11.3 Eli Lilly
11.3.1 Eli Lilly Company Details
11.3.2 Eli Lilly Business Overview
11.3.3 Eli Lilly Oral Solid Dosage Pharmaceutical Formulation Introduction
11.3.4 Eli Lilly Revenue in Oral Solid Dosage Pharmaceutical Formulation Business (2016-2021)
11.3.5 Eli Lilly Recent Development
11.4 Gilead
11.4.1 Gilead Company Details
11.4.2 Gilead Business Overview
11.4.3 Gilead Oral Solid Dosage Pharmaceutical Formulation Introduction
11.4.4 Gilead Revenue in Oral Solid Dosage Pharmaceutical Formulation Business (2016-2021)
11.4.5 Gilead Recent Development
11.5 Merck
11.5.1 Merck Company Details
11.5.2 Merck Business Overview
11.5.3 Merck Oral Solid Dosage Pharmaceutical Formulation Introduction
11.5.4 Merck Revenue in Oral Solid Dosage Pharmaceutical Formulation Business (2016-2021)
11.5.5 Merck Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Oral Solid Dosage Pharmaceutical Formulation Introduction
11.6.4 Novartis Revenue in Oral Solid Dosage Pharmaceutical Formulation Business (2016-2021)
11.6.5 Novartis Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Oral Solid Dosage Pharmaceutical Formulation Introduction
11.7.4 Pfizer Revenue in Oral Solid Dosage Pharmaceutical Formulation Business (2016-2021)
11.7.5 Pfizer Recent Development
11.8 AbbVie
11.8.1 AbbVie Company Details
11.8.2 AbbVie Business Overview
11.8.3 AbbVie Oral Solid Dosage Pharmaceutical Formulation Introduction
11.8.4 AbbVie Revenue in Oral Solid Dosage Pharmaceutical Formulation Business (2016-2021)
11.8.5 AbbVie Recent Development
11.9 Boehringer Ingelheim
11.9.1 Boehringer Ingelheim Company Details
11.9.2 Boehringer Ingelheim Business Overview
11.9.3 Boehringer Ingelheim Oral Solid Dosage Pharmaceutical Formulation Introduction
11.9.4 Boehringer Ingelheim Revenue in Oral Solid Dosage Pharmaceutical Formulation Business (2016-2021)
11.9.5 Boehringer Ingelheim Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Oral Solid Dosage Pharmaceutical Formulation Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Immediate Release
Table 3. Key Players of Extended Release
Table 4. Key Players of Others
Table 5. Global Oral Solid Dosage Pharmaceutical Formulation Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Oral Solid Dosage Pharmaceutical Formulation Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Oral Solid Dosage Pharmaceutical Formulation Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Oral Solid Dosage Pharmaceutical Formulation Market Share by Regions (2016-2021)
Table 9. Global Oral Solid Dosage Pharmaceutical Formulation Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Oral Solid Dosage Pharmaceutical Formulation Market Share by Regions (2022-2027)
Table 11. Oral Solid Dosage Pharmaceutical Formulation Market Trends
Table 12. Oral Solid Dosage Pharmaceutical Formulation Market Drivers
Table 13. Oral Solid Dosage Pharmaceutical Formulation Market Challenges
Table 14. Oral Solid Dosage Pharmaceutical Formulation Market Restraints
Table 15. Global Oral Solid Dosage Pharmaceutical Formulation Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Oral Solid Dosage Pharmaceutical Formulation Market Share by Players (2016-2021)
Table 17. Global Top Oral Solid Dosage Pharmaceutical Formulation Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oral Solid Dosage Pharmaceutical Formulation as of 2020)
Table 18. Ranking of Global Top Oral Solid Dosage Pharmaceutical Formulation Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Oral Solid Dosage Pharmaceutical Formulation Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Oral Solid Dosage Pharmaceutical Formulation Product Solution and Service
Table 22. Date of Enter into Oral Solid Dosage Pharmaceutical Formulation Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Oral Solid Dosage Pharmaceutical Formulation Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Type (2016-2021)
Table 26. Global Oral Solid Dosage Pharmaceutical Formulation Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Oral Solid Dosage Pharmaceutical Formulation Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Application (2016-2021)
Table 30. Global Oral Solid Dosage Pharmaceutical Formulation Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Oral Solid Dosage Pharmaceutical Formulation Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Oral Solid Dosage Pharmaceutical Formulation Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Oral Solid Dosage Pharmaceutical Formulation Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Oral Solid Dosage Pharmaceutical Formulation Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Oral Solid Dosage Pharmaceutical Formulation Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Oral Solid Dosage Pharmaceutical Formulation Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Oral Solid Dosage Pharmaceutical Formulation Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Oral Solid Dosage Pharmaceutical Formulation Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Oral Solid Dosage Pharmaceutical Formulation Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Oral Solid Dosage Pharmaceutical Formulation Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Oral Solid Dosage Pharmaceutical Formulation Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Oral Solid Dosage Pharmaceutical Formulation Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2022-2027) & (US$ Million)
Table 62. AstraZeneca Company Details
Table 63. AstraZeneca Business Overview
Table 64. AstraZeneca Oral Solid Dosage Pharmaceutical Formulation Product
Table 65. AstraZeneca Revenue in Oral Solid Dosage Pharmaceutical Formulation Business (2016-2021) & (US$ Million)
Table 66. AstraZeneca Recent Development
Table 67. Bristol-Myers Squibb Company Details
Table 68. Bristol-Myers Squibb Business Overview
Table 69. Bristol-Myers Squibb Oral Solid Dosage Pharmaceutical Formulation Product
Table 70. Bristol-Myers Squibb Revenue in Oral Solid Dosage Pharmaceutical Formulation Business (2016-2021) & (US$ Million)
Table 71. Bristol-Myers Squibb Recent Development
Table 72. Eli Lilly Company Details
Table 73. Eli Lilly Business Overview
Table 74. Eli Lilly Oral Solid Dosage Pharmaceutical Formulation Product
Table 75. Eli Lilly Revenue in Oral Solid Dosage Pharmaceutical Formulation Business (2016-2021) & (US$ Million)
Table 76. Eli Lilly Recent Development
Table 77. Gilead Company Details
Table 78. Gilead Business Overview
Table 79. Gilead Oral Solid Dosage Pharmaceutical Formulation Product
Table 80. Gilead Revenue in Oral Solid Dosage Pharmaceutical Formulation Business (2016-2021) & (US$ Million)
Table 81. Gilead Recent Development
Table 82. Merck Company Details
Table 83. Merck Business Overview
Table 84. Merck Oral Solid Dosage Pharmaceutical Formulation Product
Table 85. Merck Revenue in Oral Solid Dosage Pharmaceutical Formulation Business (2016-2021) & (US$ Million)
Table 86. Merck Recent Development
Table 87. Novartis Company Details
Table 88. Novartis Business Overview
Table 89. Novartis Oral Solid Dosage Pharmaceutical Formulation Product
Table 90. Novartis Revenue in Oral Solid Dosage Pharmaceutical Formulation Business (2016-2021) & (US$ Million)
Table 91. Novartis Recent Development
Table 92. Pfizer Company Details
Table 93. Pfizer Business Overview
Table 94. Pfizer Oral Solid Dosage Pharmaceutical Formulation Product
Table 95. Pfizer Revenue in Oral Solid Dosage Pharmaceutical Formulation Business (2016-2021) & (US$ Million)
Table 96. Pfizer Recent Development
Table 97. AbbVie Company Details
Table 98. AbbVie Business Overview
Table 99. AbbVie Revenue in Oral Solid Dosage Pharmaceutical Formulation Business (2016-2021) & (US$ Million)
Table 100. AbbVie Recent Development
Table 101. Boehringer Ingelheim Company Details
Table 102. Boehringer Ingelheim Business Overview
Table 103. Boehringer Ingelheim Oral Solid Dosage Pharmaceutical Formulation Product
Table 104. Boehringer Ingelheim Revenue in Oral Solid Dosage Pharmaceutical Formulation Business (2016-2021) & (US$ Million)
Table 105. Boehringer Ingelheim Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Oral Solid Dosage Pharmaceutical Formulation Market Share by Type: 2020 VS 2027
Figure 2. Immediate Release Features
Figure 3. Extended Release Features
Figure 4. Others Features
Figure 5. Global Oral Solid Dosage Pharmaceutical Formulation Market Share by Application: 2020 VS 2027
Figure 6. Hospital Pharmacy Case Studies
Figure 7. Retail Pharmacy Case Studies
Figure 8. Drug Stores Case Studies
Figure 9. Others Case Studies
Figure 10. Oral Solid Dosage Pharmaceutical Formulation Report Years Considered
Figure 11. Global Oral Solid Dosage Pharmaceutical Formulation Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Oral Solid Dosage Pharmaceutical Formulation Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Oral Solid Dosage Pharmaceutical Formulation Market Share by Regions: 2020 VS 2027
Figure 14. Global Oral Solid Dosage Pharmaceutical Formulation Market Share by Regions (2022-2027)
Figure 15. Global Oral Solid Dosage Pharmaceutical Formulation Market Share by Players in 2020
Figure 16. Global Top Oral Solid Dosage Pharmaceutical Formulation Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oral Solid Dosage Pharmaceutical Formulation as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Oral Solid Dosage Pharmaceutical Formulation Revenue in 2020
Figure 18. Global Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Type (2016-2021)
Figure 19. Global Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Type (2022-2027)
Figure 20. North America Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Oral Solid Dosage Pharmaceutical Formulation Market Share by Type (2016-2027)
Figure 22. North America Oral Solid Dosage Pharmaceutical Formulation Market Share by Application (2016-2027)
Figure 23. North America Oral Solid Dosage Pharmaceutical Formulation Market Share by Country (2016-2027)
Figure 24. United States Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Oral Solid Dosage Pharmaceutical Formulation Market Share by Type (2016-2027)
Figure 28. Europe Oral Solid Dosage Pharmaceutical Formulation Market Share by Application (2016-2027)
Figure 29. Europe Oral Solid Dosage Pharmaceutical Formulation Market Share by Country (2016-2027)
Figure 30. Germany Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Share by Region (2016-2027)
Figure 40. China Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Oral Solid Dosage Pharmaceutical Formulation Market Share by Type (2016-2027)
Figure 48. Latin America Oral Solid Dosage Pharmaceutical Formulation Market Share by Application (2016-2027)
Figure 49. Latin America Oral Solid Dosage Pharmaceutical Formulation Market Share by Country (2016-2027)
Figure 50. Mexico Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Share by Country (2016-2027)
Figure 56. Turkey Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. AstraZeneca Revenue Growth Rate in Oral Solid Dosage Pharmaceutical Formulation Business (2016-2021)
Figure 60. Bristol-Myers Squibb Revenue Growth Rate in Oral Solid Dosage Pharmaceutical Formulation Business (2016-2021)
Figure 61. Eli Lilly Revenue Growth Rate in Oral Solid Dosage Pharmaceutical Formulation Business (2016-2021)
Figure 62. Gilead Revenue Growth Rate in Oral Solid Dosage Pharmaceutical Formulation Business (2016-2021)
Figure 63. Merck Revenue Growth Rate in Oral Solid Dosage Pharmaceutical Formulation Business (2016-2021)
Figure 64. Novartis Revenue Growth Rate in Oral Solid Dosage Pharmaceutical Formulation Business (2016-2021)
Figure 65. Pfizer Revenue Growth Rate in Oral Solid Dosage Pharmaceutical Formulation Business (2016-2021)
Figure 66. AbbVie Revenue Growth Rate in Oral Solid Dosage Pharmaceutical Formulation Business (2016-2021)
Figure 67. Boehringer Ingelheim Revenue Growth Rate in Oral Solid Dosage Pharmaceutical Formulation Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

---